| Assay ID | Title | Year | Journal | Article |
|---|
| AID200189 | In vitro activity against Rhinovirus type 1B by plaque inhibition assay. | 1988 | Journal of medicinal chemistry, Oct, Volume: 31, Issue:10
| 9-Benzyl-6-(dimethylamino)-9H-purines with antirhinovirus activity. |
| AID200199 | In vitro anti-picornavirus activity against Rhinovirus type-2. | 1985 | Journal of medicinal chemistry, Jun, Volume: 28, Issue:6
| Isoxazoles with antipicornavirus activity. |
| AID511348 | Antiviral activity against Human enterovirus 71 infected in human Hep2 cells at maximum non-cytotoxic concentration after 3 days by plaque reduction assay | 2010 | Bioorganic & medicinal chemistry, Sep-01, Volume: 18, Issue:17
| New 4H-chromen-4-one and 2H-chromene derivatives as anti-picornavirus capsid-binders. |
| AID1063591 | Cytotoxicity against human HeLa cells assessed as reduction in cell viability after 3 days by XTT assay | 2014 | Bioorganic & medicinal chemistry, Feb-01, Volume: 22, Issue:3
| Synthesis and anti-rhinovirus activity of novel 3-[2-(pyridinyl)vinyl]substituted -2H-chromenes and -4H-chromen-4-ones. |
| AID86997 | Concentration required to reduce Rhino virus type 9 induced plaque formation in HeLa cell culture to 50% of control | 1986 | Journal of medicinal chemistry, Sep, Volume: 29, Issue:9
| 3,4-Dihydro-2-phenyl-2H-pyrano[2,3-b]pyridines with potent antirhinovirus activity. |
| AID1063586 | Antiviral activity against HRV 1B infected in human HeLa cells assessed as reduction in plaque number at maximum non-cytotoxic concentration after 3 days by neutral red assay | 2014 | Bioorganic & medicinal chemistry, Feb-01, Volume: 22, Issue:3
| Synthesis and anti-rhinovirus activity of novel 3-[2-(pyridinyl)vinyl]substituted -2H-chromenes and -4H-chromen-4-ones. |
| AID424993 | Therapeutic index, ratio of TC50 for human HeLa Ohio cells to IC50 for HRV1B infected in human HeLa Ohio cells | 2009 | Bioorganic & medicinal chemistry, May-15, Volume: 17, Issue:10
| Synthesis and antirhinovirus activity of new 3-benzyl chromene and chroman derivatives. |
| AID86992 | Concentration required to reduce Rhino virus type 1A induced plaque formation in HeLa cell culture to 50% of control | 1986 | Journal of medicinal chemistry, Sep, Volume: 29, Issue:9
| 3,4-Dihydro-2-phenyl-2H-pyrano[2,3-b]pyridines with potent antirhinovirus activity. |
| AID199858 | In vitro antiviral activity against Rhinovirus type-2 | 1985 | Journal of medicinal chemistry, Dec, Volume: 28, Issue:12
| [[(4,5-Dihydro-2-oxazolyl)phenoxy]alkyl]isoxazoles. Inhibitors of picornavirus uncoating. |
| AID1439647 | Antiviral activity against HRV 14 infected in human HeLa cells up to MNCC after 72 hrs by plaque reduction assay | 2017 | Bioorganic & medicinal chemistry, 04-01, Volume: 25, Issue:7
| 3-Phenylalkyl-2H-chromenes and -chromans as novel rhinovirus infection inhibitors. |
| AID1439635 | Antiviral activity against HRV 1B infected in human HeLa cells after 72 hrs by plaque reduction assay | 2017 | Bioorganic & medicinal chemistry, 04-01, Volume: 25, Issue:7
| 3-Phenylalkyl-2H-chromenes and -chromans as novel rhinovirus infection inhibitors. |
| AID86823 | Lowest concentration at which the effect on HeLa cell colony formation became apparent. | 1986 | Journal of medicinal chemistry, Sep, Volume: 29, Issue:9
| 3,4-Dihydro-2-phenyl-2H-pyrano[2,3-b]pyridines with potent antirhinovirus activity. |
| AID86994 | Concentration required to reduce Rhino virus type 64 induced plaque formation in HeLa cell culture to 50% of control | 1986 | Journal of medicinal chemistry, Sep, Volume: 29, Issue:9
| 3,4-Dihydro-2-phenyl-2H-pyrano[2,3-b]pyridines with potent antirhinovirus activity. |
| AID162259 | In vitro anti-picornavirus activity against Poliovirus type-2. | 1985 | Journal of medicinal chemistry, Jun, Volume: 28, Issue:6
| Isoxazoles with antipicornavirus activity. |
| AID103315 | Compound was tested for anti-rhinovirus type 1B activity in a plaque inhibition assay using monolayers of M-HeLa cells | 1989 | Journal of medicinal chemistry, Jan, Volume: 32, Issue:1
| Synthesis and structure-activity relationships of 2-substituted-6-(dimethylamino)-9-(4-methylbenzyl)-9H-purines with antirhinovirus activity. |
| AID634250 | Therapeutic index, ratio of TC50 for human HeLa cells to IC50 for Human rhinovirus 1B infected in human HeLa cells | 2011 | Bioorganic & medicinal chemistry, Dec-15, Volume: 19, Issue:24
| Design, synthesis and in vitro evaluation of novel chroman-4-one, chroman, and 2H-chromene derivatives as human rhinovirus capsid-binding inhibitors. |
| AID511347 | Antiviral activity against Human enterovirus 71 infected in human Hep2 cells after 2 days by plaque reduction assay | 2010 | Bioorganic & medicinal chemistry, Sep-01, Volume: 18, Issue:17
| New 4H-chromen-4-one and 2H-chromene derivatives as anti-picornavirus capsid-binders. |
| AID1439634 | Cytotoxicity against human HeLa cells assessed as reduction in cell viability by XTT assay | 2017 | Bioorganic & medicinal chemistry, 04-01, Volume: 25, Issue:7
| 3-Phenylalkyl-2H-chromenes and -chromans as novel rhinovirus infection inhibitors. |
| AID424987 | Cytotoxicity against human HeLa Ohio cells after 3 days by XTT assay | 2009 | Bioorganic & medicinal chemistry, May-15, Volume: 17, Issue:10
| Synthesis and antirhinovirus activity of new 3-benzyl chromene and chroman derivatives. |
| AID332519 | Antiviral activity against Rhinovirus 1B infected in human HeLa cells assessed as reduction in plaque formation per plate after 72 hrs | 1994 | Journal of natural products, May, Volume: 57, Issue:5
| Isolation of antirhinoviral sesquiterpenes from ginger (Zingiber officinale). |
| AID1063590 | Antiviral activity against HRV 1B infected in human HeLa cells assessed as reduction in plaque number after 3 days by neutral red assay | 2014 | Bioorganic & medicinal chemistry, Feb-01, Volume: 22, Issue:3
| Synthesis and anti-rhinovirus activity of novel 3-[2-(pyridinyl)vinyl]substituted -2H-chromenes and -4H-chromen-4-ones. |
| AID1063589 | Selectivity index, ratio of CC50 for human HeLa cells to IC50 for HRV 1B infected in human HeLa cells | 2014 | Bioorganic & medicinal chemistry, Feb-01, Volume: 22, Issue:3
| Synthesis and anti-rhinovirus activity of novel 3-[2-(pyridinyl)vinyl]substituted -2H-chromenes and -4H-chromen-4-ones. |
| AID1439636 | Selectivity index, ratio of CC50 for human HeLa cells to IC50 for HRV 1B infected in human HeLa cells | 2017 | Bioorganic & medicinal chemistry, 04-01, Volume: 25, Issue:7
| 3-Phenylalkyl-2H-chromenes and -chromans as novel rhinovirus infection inhibitors. |
| AID511340 | Cytotoxicity against human HeLa cells assessed as maximum non-cytotoxic concentration after 3 days by XTT assay | 2010 | Bioorganic & medicinal chemistry, Sep-01, Volume: 18, Issue:17
| New 4H-chromen-4-one and 2H-chromene derivatives as anti-picornavirus capsid-binders. |
| AID634248 | Cytotoxicity against human HeLa cells after 3 days by XTT based ELISA reader | 2011 | Bioorganic & medicinal chemistry, Dec-15, Volume: 19, Issue:24
| Design, synthesis and in vitro evaluation of novel chroman-4-one, chroman, and 2H-chromene derivatives as human rhinovirus capsid-binding inhibitors. |
| AID200198 | Evaluated for inhibitory activity against rhinovirus type 5 | 1990 | Journal of medicinal chemistry, May, Volume: 33, Issue:5
| Antirhinovirus activity of 6-anilino-9-benzyl-2-chloro-9H-purines. |
| AID634249 | Antiviral activity against Human rhinovirus 1B infected in human HeLa cells assessed as inhibition of virus induced-plaque formation after 3 days by neutral red-based plaque reduction assay | 2011 | Bioorganic & medicinal chemistry, Dec-15, Volume: 19, Issue:24
| Design, synthesis and in vitro evaluation of novel chroman-4-one, chroman, and 2H-chromene derivatives as human rhinovirus capsid-binding inhibitors. |
| AID200197 | Evaluated for inhibitory activity against rhinovirus type 4 | 1990 | Journal of medicinal chemistry, May, Volume: 33, Issue:5
| Antirhinovirus activity of 6-anilino-9-benzyl-2-chloro-9H-purines. |
| AID511341 | Antiviral activity against Human rhinovirus 1B infected in human HeLa cells after 3 days by plaque reduction assay | 2010 | Bioorganic & medicinal chemistry, Sep-01, Volume: 18, Issue:17
| New 4H-chromen-4-one and 2H-chromene derivatives as anti-picornavirus capsid-binders. |
| AID115933 | In vitro antiviral activity against mice infected intracerebrally with Poliovirus type-2; Inactive | 1985 | Journal of medicinal chemistry, Dec, Volume: 28, Issue:12
| [[(4,5-Dihydro-2-oxazolyl)phenoxy]alkyl]isoxazoles. Inhibitors of picornavirus uncoating. |
| AID200195 | Evaluated for inhibitory activity against rhinovirus type 2 | 1990 | Journal of medicinal chemistry, May, Volume: 33, Issue:5
| Antirhinovirus activity of 6-anilino-9-benzyl-2-chloro-9H-purines. |
| AID1439633 | Cytotoxicity against human HeLa cells assessed as changes in morphology after 3 days by microscopic method | 2017 | Bioorganic & medicinal chemistry, 04-01, Volume: 25, Issue:7
| 3-Phenylalkyl-2H-chromenes and -chromans as novel rhinovirus infection inhibitors. |
| AID424989 | Antiviral activity against HRV 1B infected in human HeLa Ohio cells assessed as reduction in viral plaque formation after 3 days by neutral red uptake assay | 2009 | Bioorganic & medicinal chemistry, May-15, Volume: 17, Issue:10
| Synthesis and antirhinovirus activity of new 3-benzyl chromene and chroman derivatives. |
| AID511344 | Antiviral activity against Human rhinovirus 14 infected in human HeLa cells at maximum non-cytotoxic concentration after 3 days by plaque reduction assay | 2010 | Bioorganic & medicinal chemistry, Sep-01, Volume: 18, Issue:17
| New 4H-chromen-4-one and 2H-chromene derivatives as anti-picornavirus capsid-binders. |
| AID634247 | Cytotoxicity against human HeLa cells after 3 days by microscopic analysis | 2011 | Bioorganic & medicinal chemistry, Dec-15, Volume: 19, Issue:24
| Design, synthesis and in vitro evaluation of novel chroman-4-one, chroman, and 2H-chromene derivatives as human rhinovirus capsid-binding inhibitors. |
| AID634254 | Antiviral activity against Human rhinovirus 14 infected in human HeLa cells assessed as inhibition of virus induced-plaque formation at 25 uM after 3 days by neutral red-based plaque reduction assay | 2011 | Bioorganic & medicinal chemistry, Dec-15, Volume: 19, Issue:24
| Design, synthesis and in vitro evaluation of novel chroman-4-one, chroman, and 2H-chromene derivatives as human rhinovirus capsid-binding inhibitors. |
| AID511339 | Cytotoxicity against human HeLa cells after 3 days by XTT assay | 2010 | Bioorganic & medicinal chemistry, Sep-01, Volume: 18, Issue:17
| New 4H-chromen-4-one and 2H-chromene derivatives as anti-picornavirus capsid-binders. |
| AID511346 | Cytotoxicity against human Hep2 cells assessed as maximum non-cytotoxic concentration after 3 days by XTT assay | 2010 | Bioorganic & medicinal chemistry, Sep-01, Volume: 18, Issue:17
| New 4H-chromen-4-one and 2H-chromene derivatives as anti-picornavirus capsid-binders. |
| AID200192 | Inhibitory activity against rhinovirus type 1B | 1990 | Journal of medicinal chemistry, May, Volume: 33, Issue:5
| Antirhinovirus activity of 6-anilino-9-benzyl-2-chloro-9H-purines. |
| AID424991 | Antiviral activity against HRV 14 infected in human HeLa Ohio cells assessed as reduction in viral plaque formation after 3 days by neutral red uptake assay | 2009 | Bioorganic & medicinal chemistry, May-15, Volume: 17, Issue:10
| Synthesis and antirhinovirus activity of new 3-benzyl chromene and chroman derivatives. |
| AID424988 | Cytotoxicity against human HeLa Ohio cells assessed as maximal non-cytotoxic concentration after 3 days by XTT assay | 2009 | Bioorganic & medicinal chemistry, May-15, Volume: 17, Issue:10
| Synthesis and antirhinovirus activity of new 3-benzyl chromene and chroman derivatives. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |